PSA Vice President Professor Mark Naunton MPS[/caption]
The role of the pharmacist in onychomycosis
Onychomycosis is a fungal infection of the nails. If left untreated, it can cause pain, discomfort, spread of infection and physical impairment, negatively impacting quality of life.
Coping with COVID-19: the Royal Melbourne Hospital experience
COVID-19 has fostered an even closer relationship between the pharmacy and wards of the Royal Melbourne Hospital.
Australians line up at pharmacies for winter dose
On 11 July, 7.4 million Australians became eligible for a COVID-19 winter dose after the eligibility criteria widened.
Have your voice heard with PSA’s Communities of Specialty Interest
Pharmacists across the country have a new way to connect, collaborate and drive the profession forward, with the launch of PSA’s Communities of Specialty Interest (CSIs).
A better pharmacy experience leads to increased medicine adherence, study shows
There is a link between the perceived quality of care provided by community pharmacists and patients’ adherence to prescribed medicine, new Australian research has shown.
What went right (and wrong) with Australia’s COVID-19 response?
COVID-19 enquiry criticises delays involving pharmacists in rollout, calling for urgent harmonisation of vaccine scope.
